Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction

Only sparse data was available on long-term of Takotusbo Cardiomyopathy (TC). Previous studies suggested prognosis is not necessarily benign. We report the long-term follow-up of 12 TC patients actively managed with risk factor reduction. Retrospective analysis of all patients diagnosed with TC at o...

Full description

Bibliographic Details
Main Authors: Koroush Khalighi, Mohammad Umar Farooq, Thein Tun Aung, Swe Oo
Format: Article
Language:English
Published: MDPI AG 2015-11-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:http://www.mdpi.com/2308-3425/2/4/273
id doaj-127b1f19069a4e66a4440eed001c5338
record_format Article
spelling doaj-127b1f19069a4e66a4440eed001c53382020-11-25T00:14:33ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252015-11-012427328110.3390/jcdd2040273jcdd2040273Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor ReductionKoroush Khalighi0Mohammad Umar Farooq1Thein Tun Aung2Swe Oo3Department of Cardiovascular Disease, Easton Hospital Easton, PA Clinical Professor of Medicine, Drexel University, School of Medicine Easton Cardiovascular Associates 2001 Fairview Ave, Easton, PA 18042, USADepartment of Medicine, Easton Hospital, 250 South 21 street, Easton, PA 18042, USADepartment of Cardiovascular Disease, Wright State University, 921 Wilmington Ave, Apt D, Dayton, OH 45420, USADepartment of Medicine, Easton Hospital, 250 South 21 street, Easton, PA 18042, USAOnly sparse data was available on long-term of Takotusbo Cardiomyopathy (TC). Previous studies suggested prognosis is not necessarily benign. We report the long-term follow-up of 12 TC patients actively managed with risk factor reduction. Retrospective analysis of all patients diagnosed with TC at our hospital between 1998 and 2010. We identified 12 patients with TC among 1651 cases of emergent left heart catheterization over 12 years. Mean follow-up time was 8.3 ± 3.6 years. All were female, 87% had hypertension, 25% had history of Coronary Artery Disease (CAD), 67% had hyperlipidemia, 44% had some preceding emotional trauma, and 44% had some physical/physiological stress. Previous studies have shown that over 50% of TC patients experience future cardiac events, and 10% have a recurrence of TC. Patients were prescribed therapeutic lifestyle changes (TLC) and guideline directed medical therapy (GDMT) for aggressive risk factor reduction. TLC included diet, exercise, and cardiac rehabilitation. GDMT often included aspirin, beta-blockers, ACE-inhibitors, and statins. Follow-up echocardiograms showed recovery and maintenance of the ejection fraction. There was no cardiac mortality and no recurrences of TC. Aggressive risk factor reduction with TLC and GDMT may be effective in improving the long term outcomes of patients with TC.http://www.mdpi.com/2308-3425/2/4/273Takotusbo Cardiomyopathy (TC)Myocardial Infarction with Normal Coronary Arteries (MINCA)stress-induced cardiomyopathyCoronary Artery Disease (CAD)
collection DOAJ
language English
format Article
sources DOAJ
author Koroush Khalighi
Mohammad Umar Farooq
Thein Tun Aung
Swe Oo
spellingShingle Koroush Khalighi
Mohammad Umar Farooq
Thein Tun Aung
Swe Oo
Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction
Journal of Cardiovascular Development and Disease
Takotusbo Cardiomyopathy (TC)
Myocardial Infarction with Normal Coronary Arteries (MINCA)
stress-induced cardiomyopathy
Coronary Artery Disease (CAD)
author_facet Koroush Khalighi
Mohammad Umar Farooq
Thein Tun Aung
Swe Oo
author_sort Koroush Khalighi
title Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction
title_short Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction
title_full Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction
title_fullStr Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction
title_full_unstemmed Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction
title_sort takotsubo cardiomyopathy: a long term follow-up shows benefit with risk factor reduction
publisher MDPI AG
series Journal of Cardiovascular Development and Disease
issn 2308-3425
publishDate 2015-11-01
description Only sparse data was available on long-term of Takotusbo Cardiomyopathy (TC). Previous studies suggested prognosis is not necessarily benign. We report the long-term follow-up of 12 TC patients actively managed with risk factor reduction. Retrospective analysis of all patients diagnosed with TC at our hospital between 1998 and 2010. We identified 12 patients with TC among 1651 cases of emergent left heart catheterization over 12 years. Mean follow-up time was 8.3 ± 3.6 years. All were female, 87% had hypertension, 25% had history of Coronary Artery Disease (CAD), 67% had hyperlipidemia, 44% had some preceding emotional trauma, and 44% had some physical/physiological stress. Previous studies have shown that over 50% of TC patients experience future cardiac events, and 10% have a recurrence of TC. Patients were prescribed therapeutic lifestyle changes (TLC) and guideline directed medical therapy (GDMT) for aggressive risk factor reduction. TLC included diet, exercise, and cardiac rehabilitation. GDMT often included aspirin, beta-blockers, ACE-inhibitors, and statins. Follow-up echocardiograms showed recovery and maintenance of the ejection fraction. There was no cardiac mortality and no recurrences of TC. Aggressive risk factor reduction with TLC and GDMT may be effective in improving the long term outcomes of patients with TC.
topic Takotusbo Cardiomyopathy (TC)
Myocardial Infarction with Normal Coronary Arteries (MINCA)
stress-induced cardiomyopathy
Coronary Artery Disease (CAD)
url http://www.mdpi.com/2308-3425/2/4/273
work_keys_str_mv AT koroushkhalighi takotsubocardiomyopathyalongtermfollowupshowsbenefitwithriskfactorreduction
AT mohammadumarfarooq takotsubocardiomyopathyalongtermfollowupshowsbenefitwithriskfactorreduction
AT theintunaung takotsubocardiomyopathyalongtermfollowupshowsbenefitwithriskfactorreduction
AT sweoo takotsubocardiomyopathyalongtermfollowupshowsbenefitwithriskfactorreduction
_version_ 1725389839474360320